Verrica Pharmaceuticals Inc. Annual Interest Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2023.
  • Verrica Pharmaceuticals Inc. Interest Expense for the quarter ending June 30, 2024 was $2.37M.
  • Verrica Pharmaceuticals Inc. Interest Expense for the twelve months ending June 30, 2024 was $8.65M, a 35938% increase year-over-year.
  • Verrica Pharmaceuticals Inc. annual Interest Expense for 2023 was $3.96M, a 82.4% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Interest Expense for 2022 was $2.17M, a 49.4% decline from 2021.
  • Verrica Pharmaceuticals Inc. annual Interest Expense for 2021 was $4.3M, a 41.6% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.96M +$1.79M +82.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $2.17M -$2.12M -49.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $4.3M +$1.26M +41.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $3.03M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.